A novel locus for arterial hypertension on chromosome 1p36 maps to a metabolic syndrome trait cluster in the Sorbs, a Slavic population isolate in Germany

Journal of Hypertension

Volumn 27, Issue 5, 2009, Pages 983-990

  Hoffmann, Katrin ^a,b,c   Planitz, Christian ^d   Rüschendorf, Franz ^c   Müller Myhsok, Bertram ^e   Stassen, Hans H ^f   Lucke, Barbara ^a,c   Mattheisen, Manuel ^g   Stumvoll, Michael ^h   Bochmann, Rolf ^d   Zschornackj, Martin ⁱ   Wienker, Thomas F ^c,g   Nürnberg, Peter ^c,j   Reis, André ^k   Luft, Friedrich C ^a   Lindner, Tom H ^h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ Malteser Hospital   (Germany)

^j UNIVERSITY OF COLOGNE   (Germany)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

Essential hypertension; Genetics; Germans; Hypertension; Isolated population; Linkage analysis; Primary hypertension; Sorbs

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHROMOSOME 1P; CHROMOSOME MAP; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRAIT; GENOTYPE; GERMANY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROSATELLITE MARKER; OBESITY; PRIORITY JOURNAL;

EID: 67649635079     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328328123d     Document Type: Article

References (64)

1. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162:975-982.
2. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third Nation al Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
3. FBPP Investigators. Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension 2002; 39:3-9.
4. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
5. Hong Y, de Faire U, Heller DA, McClearn GE, Pedersen N. Genetic and environmental influences on blood pressure in elderly twins. Hypertension 1994; 24:663-670.
6. Stoll M, Kwitek-Black AE, Cowley AW Jr, Harris EL, Harrap SB, Krieger JE, et al. New target regions for human hypertension via comparative genomics. Genome Res 2000; 10:473-482.
7. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344:101-106.
8. Peltonen L Molecular background of the Finnish disease heritage. Ann Med 1997; 29:553-556.
9. Peltonen L Positional cloning of disease genes: advantages of genetic isolates. Hum Hered 2000; 50:66-75.
10. Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999; 8:1913-1923.
11. Arcos-Burgos M, Muenke M. Genetics of population isolates. Clin Genet 2002; 61:233-247.
12. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447:661-678.
13. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592-599.
14. Kunze P. Short history of the Sorbs: a cultural-historical overview. Domowina Verlag; 2nd ed. 1997.
15. Oschlies W. The Sorbs: a Slavic population in Eastern Germany [in German]. Bad Godesberg, Bonn: Friedrich-Ebert-Stiftung; 1991.
16. Nielsen GR. In search of a home: nineteenth-century Wendish immigration. 1st ed. College Station, TX: Texas A & M University Press; 1989.
17. Pettenkofer HJ, Thomas K, Voigt GE. Blood group and blood factor distribution in the Sorbs of Lusatia [in German]. Blut 1958; 4:128-130.
18. Thomas K. The frequency of the blood group marker S (Walsh and Montgomery) of the MNSs blood group system in the Sorbian population of Lusatia [in German]. Dtsch Gesundh Wes 1962; 17:613-614.
19. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 1998; 63:861-869.
20. Hoffmann K, Dreger CK, Olins AL, Olins DE, Shultz LD, Lucke B, et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly). Nat Genet 2002; 31:410-414.
21. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63:259-266.
22. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. GRR: graphical representation of relationship errors. Bioinformatics 2001; 17:742-743.
23. Lander E, Kruglyak L Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11:241-247.
24. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin: rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30:97-101.
25. Wiltshire S, Cardon LR, McCarthy MI. Evaluating the results of genomewide linkage scans of complex traits by locus counting. Am J Hum Genet 2002; 71:1175-1182.
26. Ott J, Bhat A. Linkage analysis in heterogeneous and complex traits. Eur Child Adolesc Psychiatry 1999; 8 (Suppl 3):43-46.
27. Lindner TH, Hoffmann K. easyLINKAGE: a PERL script for easy and automated two-/multipoint linkage analyses. Bioinformatics 2005; 21:405-407.
28. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000; 25:12-13.
29. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI, Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 1999; 21:213-215.
30. Whittemore AS, Halpern J. A class of tests for linkage using affected pedigree members. Biometrics 1994; 50:118-127.
31. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997; 61:1179-1188.
32. Freedman BI, Langefeld CD, Rich SS, Valis CJ, Sale MM, Williams AH, et al. A genome scan for ESRD in black families enriched for nondiabetic nephropathy. J Am Soc Nephrol 2004; 15:2719-2727.
33. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316:1488-1491.
34. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008; 40:217-224.
35. Glenn CL, Wang WY, Benjafield AV, Morris BJ. Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet 2000; 9:1943-1949.
36. Benjafield AV, Wang WY, Speirs HJ, Morris BJ. Genome-wide scan for hypertension in Sydney sibships: the GENIHUSS study. Am J Hypertens 2005; 18:828-832.
37. Geurts JM, Janssen RG, van Greevenbroek MM, van der Kallen CJ, Cantor RM, Bu X, et al. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum Mol Genet 2000; 9:2067-2074.
38. Pausova Z, Gaudet D, Gossard F, Bernard M, Kaldunski ML, Jomphe M, et al. Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension 2005; 46:1280-1285.
39. Gorlova OY, Amos CI, Wang NW, Shete S, Turner ST, Boerwinkle E. Genetic linkage and imprinting effects on body mass index in children and young adults. Eur J Hum Genet 2003; 11:425-432.
40. Voruganti VS, Goring HH, Diego VP, Cai G, Mehta NR, Haack K, et al. Genome-wide scan for serum ghrelin detects linkage on chromosome 1 p36 in Hispanic children: results from the Viva La Familia study. Pediatr Res 2007; 62:445-450.
41. Puppala S, Dodd GD, Fowler S, Arya R, Schneider J, Farook VS, et al. A genomewide search finds major susceptibility loci for gall bladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006; 78:377-392.
42. Cai G, Cole SA, Freeland-Graves JH, MacCluer JW, Blangero J, Comuzzie AG. Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: the San Antonio Family Heart Study. Hum Biol 2004; 76:651-665.
43. Iwasaki N, Cox NJ, Wang YQ, Schwarz PE, Bell GI, Honda M, et al. Mapping genes influencing type 2 diabetes risk and BMI in Japanese subjects. Diabetes 2003; 52:209-213.
44. Hoffmann K, Mattheisen M, Dahm S, Nurnberg P, Roe C, Johnson J, et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1 p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 2007; 50:1418-1422.
45. Hamet P, Merlo E, Seda O, Broeckel U, Tremblay J, Kaldunski M, et al. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet 2005; 76:815-832.
46. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361:2118-2123.
47. Samani NJ. Genome scans for hypertension and blood pressure regulation. Am J Hypertens 2003; 16:167-171.
48. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
49. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 1995; 10:394-399.
50. Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 1996; 347:88-91.
51. Barr M, MacKenzie SM, Friel EC, Holloway CD, Wilkinson DM, Brain NJ, et al. Polymorphic variation in the 11 beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency. Hypertension 2007; 49:113-119.
52. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289:119-123.
53. Pujo L, Fagart J, Gary F, Papadimitriou DT, Claes A, Jeunemaitre X, Zennaro MC. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat 2007; 28:33-40.
54. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995; 11:76-82.
55. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79:407-414.
56. Tamura H, Schild L, Enomoto N, Matsui N, Marumo F, Rossier BC. Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene. J Clin Invest 1996; 97:1780-1784.
57. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112.
58. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 2003; 100:680-684.
59. Xie J, Craig L, Cobb MH, Huang CL. Role of with-no-lysine [K] kinases in the pathogenesis of Gordon's syndrome. Pediatr Nephrol 2006; 21:1231-1236.
60. Gong M, Zhang H, Schulz H, Lee YA, Sun K, Bahring S, etal. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet 2003; 12:1273-1277.
61. Ehret GB, Morrison AC, O'Connor AA, Grove ML, Baird L, Schwander K, et al. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet 2008; 16:1507-1511.
62. Helgason A, Yngvadottir B, Hrafnkelsson B, Gulcher J, Stefansson K. An Icelandic example of the impact of population structure on association studies. Nat Genet 2005; 37:90-95.
63. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9:356-369.
64. Varilo T, Peltonen L. Isolates and their potential use in complex gene mapping efforts. Curr Opin Genet Dev 2004; 14:316-323.